SK143299A3 - BETA-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDESì (54) ENCODING THE SAME - Google Patents
BETA-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDESì (54) ENCODING THE SAME Download PDFInfo
- Publication number
- SK143299A3 SK143299A3 SK1432-99A SK143299A SK143299A3 SK 143299 A3 SK143299 A3 SK 143299A3 SK 143299 A SK143299 A SK 143299A SK 143299 A3 SK143299 A3 SK 143299A3
- Authority
- SK
- Slovakia
- Prior art keywords
- amino acid
- polynucleotide
- protein
- sequence
- bbp1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6458397P | 1997-04-16 | 1997-04-16 | |
PCT/US1998/007462 WO1998046636A2 (en) | 1997-04-16 | 1998-04-14 | β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
SK143299A3 true SK143299A3 (en) | 2000-09-12 |
Family
ID=22056941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1432-99A SK143299A3 (en) | 1997-04-16 | 1998-04-14 | BETA-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDESì (54) ENCODING THE SAME |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0975753A2 (zh) |
JP (3) | JP2001523093A (zh) |
KR (1) | KR20010006393A (zh) |
CN (2) | CN1196785C (zh) |
AU (1) | AU740445B2 (zh) |
BR (1) | BR9808562A (zh) |
CA (1) | CA2286484A1 (zh) |
EA (1) | EA004256B1 (zh) |
EE (1) | EE9900482A (zh) |
GE (1) | GEP20043386B (zh) |
HU (1) | HUP0003116A3 (zh) |
ID (1) | ID24914A (zh) |
IL (3) | IL132236A0 (zh) |
NO (1) | NO995062L (zh) |
NZ (1) | NZ500216A (zh) |
SK (1) | SK143299A3 (zh) |
UA (1) | UA72875C2 (zh) |
WO (1) | WO1998046636A2 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005295B1 (en) | 1997-04-16 | 2006-02-28 | Wyeth | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
US6787319B2 (en) * | 1997-04-16 | 2004-09-07 | American Home Products Corp. | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
EP1121432A2 (en) * | 1998-10-13 | 2001-08-08 | American Home Products Corporation | G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
US6455082B1 (en) * | 1999-04-26 | 2002-09-24 | Nestec S.A. | Shelf-stable calcium fortified milk and dairy products |
AU4183200A (en) * | 1999-10-21 | 2001-04-30 | Panorama Research, Inc. | A general method for optimizing the expression of heterologous proteins |
US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
US7807171B2 (en) | 2003-07-25 | 2010-10-05 | Ac Immune Sa | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
EP3527220A1 (en) | 2010-08-12 | 2019-08-21 | AC Immune S.A. | Vaccine engineering |
US9687447B2 (en) | 2010-10-26 | 2017-06-27 | Ac Immune S.A. | Method for preparing liposome-based constructs |
CN102060912B (zh) * | 2010-11-22 | 2012-11-14 | 清华大学 | 淀粉样蛋白寡聚体构象型抗原表位多肽及其应用 |
CN111320678B (zh) * | 2020-03-09 | 2023-06-09 | 安亭生物有限责任公司 | 抗菌肽突变体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0274826B1 (en) * | 1986-11-17 | 1998-08-12 | Scios Inc. | Recombinant Alzheimer's amyloid protein |
IL115743A0 (en) * | 1994-10-28 | 1996-01-19 | American Nat Red Cross | A mammal with cells containing a transgene and its production |
US5786180A (en) * | 1995-02-14 | 1998-07-28 | Bayer Corporation | Monoclonal antibody 369.2B specific for β A4 peptide |
-
1998
- 1998-04-14 EA EA199900941A patent/EA004256B1/ru not_active IP Right Cessation
- 1998-04-14 HU HU0003116A patent/HUP0003116A3/hu unknown
- 1998-04-14 WO PCT/US1998/007462 patent/WO1998046636A2/en active Application Filing
- 1998-04-14 IL IL13223698A patent/IL132236A0/xx active IP Right Grant
- 1998-04-14 ID IDW991187D patent/ID24914A/id unknown
- 1998-04-14 AU AU71156/98A patent/AU740445B2/en not_active Ceased
- 1998-04-14 GE GE3744A patent/GEP20043386B/en unknown
- 1998-04-14 BR BR9808562-0A patent/BR9808562A/pt not_active Application Discontinuation
- 1998-04-14 KR KR1019997009480A patent/KR20010006393A/ko not_active Application Discontinuation
- 1998-04-14 SK SK1432-99A patent/SK143299A3/sk unknown
- 1998-04-14 UA UA99116193A patent/UA72875C2/uk unknown
- 1998-04-14 NZ NZ500216A patent/NZ500216A/xx unknown
- 1998-04-14 EE EEP199900482A patent/EE9900482A/xx unknown
- 1998-04-14 CA CA002286484A patent/CA2286484A1/en not_active Abandoned
- 1998-04-14 CN CNB988043173A patent/CN1196785C/zh not_active Expired - Fee Related
- 1998-04-14 JP JP54419698A patent/JP2001523093A/ja active Pending
- 1998-04-14 EP EP98918186A patent/EP0975753A2/en not_active Withdrawn
- 1998-04-14 CN CNA200510052975XA patent/CN1690203A/zh active Pending
-
1999
- 1999-10-06 IL IL132236A patent/IL132236A/en not_active IP Right Cessation
- 1999-10-15 NO NO995062A patent/NO995062L/no not_active Application Discontinuation
-
2006
- 2006-11-05 IL IL179047A patent/IL179047A0/en unknown
-
2007
- 2007-12-28 JP JP2007339660A patent/JP2008104465A/ja active Pending
-
2008
- 2008-06-18 JP JP2008159606A patent/JP2008253275A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ID24914A (id) | 2000-08-31 |
JP2008253275A (ja) | 2008-10-23 |
BR9808562A (pt) | 2000-05-23 |
EE9900482A (zh) | 2000-06-15 |
CN1268973A (zh) | 2000-10-04 |
CN1690203A (zh) | 2005-11-02 |
UA72875C2 (uk) | 2005-05-16 |
WO1998046636A3 (en) | 1999-01-28 |
WO1998046636A2 (en) | 1998-10-22 |
IL132236A (en) | 2007-03-08 |
NZ500216A (en) | 2001-06-29 |
CA2286484A1 (en) | 1998-10-22 |
NO995062L (no) | 1999-12-14 |
AU740445B2 (en) | 2001-11-01 |
EA004256B1 (ru) | 2004-02-26 |
GEP20043386B (en) | 2004-02-10 |
AU7115698A (en) | 1998-11-11 |
CN1196785C (zh) | 2005-04-13 |
NO995062D0 (no) | 1999-10-15 |
HUP0003116A3 (en) | 2003-03-28 |
EA199900941A1 (ru) | 2000-06-26 |
JP2001523093A (ja) | 2001-11-20 |
IL179047A0 (en) | 2007-03-08 |
IL132236A0 (en) | 2001-03-19 |
HUP0003116A2 (hu) | 2001-01-29 |
JP2008104465A (ja) | 2008-05-08 |
KR20010006393A (ko) | 2001-01-26 |
EP0975753A2 (en) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008104465A (ja) | β−アミロイドペプチド結合タンパク質及びそれらをコードするポリヌクレオチド | |
US7101973B2 (en) | β-amyloid peptide-binding proteins and polynucleotides encoding the same | |
US6468791B1 (en) | Chromosone 1 gene and gene products related to Alzheimer's disease | |
US7005295B1 (en) | β-amyloid peptide-binding proteins and polynucleotides encoding the same | |
IE66226B1 (en) | Human macrophage inflammatory protein 2-alpha | |
US6248555B1 (en) | Genetic alterations related to familial alzheimer's disease | |
WO2002033114A2 (en) | Protein-protein interactions in neurodegenerative diseases | |
WO2000040721A1 (en) | Monocyte-derived nucleic acids and related compositions and methods | |
CZ361299A3 (cs) | Proteiny vázající β-amyloidový peptid a polynukleotidy, které je kódují | |
US20050170408A1 (en) | G protein-binding proteins and polynucleotides encoding the same | |
IL151211A (en) | A polypeptide that interacts with the parkin gene, pharmacological compositions containing it for use in the treatment of neurodegenerative pathologies and a method for its preparation | |
AU2008203406A1 (en) | Beta-amyloid peptide-binding proteins and polynucleotides encoding the same | |
JP2002153290A (ja) | 新規unc5H4遺伝子及びそれにコードされる蛋白質 | |
AU2002305397A1 (en) | Beta-amyloid peptide-binding proteins and polynucleotides encoding the same | |
MXPA98001603A (en) | Genetic alterations related to the disease of alzheimer heredita |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB9A | Suspension of patent application procedure |